Recent Trading Insights from Advanced Medical Solutions Group
Key Information on Trading Activities
FORM 8.5 (EPT/RI)
Public Disclosure by an Exempt Principal Trader
This document pertains to an exempt principal trader who conducts transactions in a client-serving capacity, as defined by the Takeover Code.
Essential Details
1. Key Information
(a) Name of Exempt Principal Trader: Investec Bank plc.
(b) Relevant Securities Related to: Advanced Medical Solutions Group plc.
(c) Connection with the Offer: Investec acts as the Financial Adviser, NOMAD, and Corporate Broker for Advanced Medical Solutions Group plc.
(d) Date of Trading Activity: Details concerning transactions involving securities were recorded recently.
(e) Other Parties Disclosed: Not applicable; there are no additional parties involved in this transaction.
Recent Dealings by the Exempt Principal Trader
2. Trading Activities Overview
The specifics of the trades undertaken by the exempt principal traders are outlined, emphasizing the transparent nature of the dealings as dictated by the established regulations.
Purchases and Sales Summary
Ordinary Shares Transactions
Details of the ordinary shares transactions indicate:
- Purchases: 85,194 shares were acquired at a maximum price of 202.5, with a minimum price of 198.4.
- Sales: 86,400 shares sold, similarly noting the price range as specified.
Cash-Settled Derivative Transactions
No derivative transactions were recorded in the specified time frame.
Options and Other Transactions
No stock-settled derivatives transactions were conducted, noting inactive options for relevant securities during this period.
Other Relevant Information
3. Additional Disclosures
Indemnity and Dealing Arrangements
No indemnity or deal arrangements exist with other parties related to the securities.
Agreements Regarding Voting Rights
No agreements exist concerning the voting rights of the relevant securities as stated.
Conclusion and Contact Information
Date of Disclosure: The relevant information was disclosed publicly on a recent date for full transparency.
Contact Person: Abhishek Gawde
Contact Number: +91 9923757332
This document represents a commitment to transparency and compliance under the regulations governing trading activities. For further clarifications regarding the disclosures made, the Panel’s Market Surveillance Unit is at your service by contacting +44 (0)20 7638 0129.
Frequently Asked Questions
What is the purpose of this document?
This document provides public updates regarding trading activities by an exempt principal trader in relation to Advanced Medical Solutions Group plc.
Who is the exempt principal trader involved?
The exempt principal trader referenced in this document is Investec Bank plc.
What securities are being discussed?
The securities in focus are the ordinary shares of Advanced Medical Solutions Group plc.
Were any derivatives traded?
No cash-settled or stock-settled derivatives transactions were reported in this trading period.
How can I contact for more information?
For additional inquiries, you can reach out to Abhishek Gawde at +91 9923757332.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.